Legal Opinion
Amgen Inc. v. Price
District Court, District of Columbia
Decided February 17, 2018No. Civil Action No. 2017-1006Published
1Opinion of the Court
UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA AMGEN INC., Plaintiff, v. ALEX AZAR II, Secretary, U.S. Department of Health and Human Services, et al., Civil Action No. 17-1006 (RDM) Defendants, and AMNEAL PHARMACEUTICALS, LLC, Intervenor-Defendant. MEMORANDUM OPINION Amgen brought this action to challenge the decision of the Food and Drug Administration (“FDA”) denying Amgen pediatric exclusivity for its drug, Sensipar (cinacalcet hydrochloride). In an earlier opinion and order, the Court granted the FDA summary judgment on all but one of Amgen’s claims: its claim that the…
2Cases cited6 opinions
- Motor Vehicle Mfrs. Assn. of United States, Inc. v. State Farm Mut. Automobile Ins. Co.Supreme Court of the United States · 1983
- Marsh v. Oregon Natural Resources CouncilSupreme Court of the United States · 1989
- Alaska Department of Environmental Conservation v. Environmental Protection AgencySupreme Court of the United States · 2004
- Advocates for Highway & Auto Safety v. Federal Motor Carrier Safety AdministrationCourt of Appeals for the D.C. Circuit · 2005
- Regents of the University of California v. BurwellDistrict Court, District of Columbia · 2016
1 more not listed; retrieve them via the Exa API.